Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Dynavax Technologies (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
860
total citations
- FWCI
- 24.55
- Percentile
- 100%
- References
- 98
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Innate immune system
- Toll-like receptor
- Immunology
- Receptor
- Pattern recognition receptor
- Immunity
- Autoimmunity
- Inflammation
No related works found for this paper.